Echinocandin and ethanol lock therapy treatment of fungal catheter infections

Pediatric Infectious Disease Journal

Volumn 32, Issue 3, 2013, Pages 289-291

  Pieroni, Kevin P ^a   Nespor, Colleen ^b   Poole, Robert L ^b   Kerner Jr , John A ^a,b   Berquist, William E ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LUCILE PACKARD CHILDREN S HOSPITAL   (United States)

Author keywords

Catheter infection; Ethanol locks; Fungal infections

Indexed keywords

ALCOHOL; AMPHOTERICIN B; CASPOFUNGIN; CEPHALOSPORIN; ECHINOCANDIN; FLUCONAZOLE; GRISEOFULVIN; HEPARIN; INFUSION FLUID; MICAFUNGIN; SODIUM CHLORIDE; VANCOMYCIN; VORICONAZOLE;

ADULT; ARTICLE; CANDIDIASIS; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CHILD; CLINICAL ARTICLE; ECHOCARDIOGRAPHY; FEVER; FUNGUS GROWTH; GASTROINTESTINAL MOTILITY DISORDER; GASTROSCHISIS; HUMAN; INFANT; INTESTINAL FAILURE; INTESTINE PSEUDOOBSTRUCTION; INTESTINE VOLVULUS; INTRAVENOUS CATHETER; MYCOSIS; OPHTHALMOLOGY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROPHYLAXIS; SCHOOL CHILD; SYSTEMIC THERAPY;

ANTIFUNGAL AGENTS; CATHETER-RELATED INFECTIONS; CATHETERS; CHILD; CHILD, PRESCHOOL; DISINFECTANTS; DISINFECTION; ECHINOCANDINS; ETHANOL; FUNGEMIA; FUNGI; HUMANS; INFANT; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84876286673     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3182784867     Document Type: Article

References (17)

1. Chambers ST, Peddie B, Pithie A. Ethanol disinfection of plastic-adherent micro-organisms. J Hosp Infect. 2006;63:193-196.
2. Sissons CH, Wong L, Cutress TW. Inhibition by ethanol of the growth of bio-film and dispersed microcosm dental plaques. Arch Oral Biol. 1996;41:27-34.
3. Jones BA, Hull MA, Richardson DS, et al. Efficacy of ethanol locks in reducing central venous catheter infections in pediatric patients with intestinal failure. J Pediatr Surg. 2010;45:1287-1293.
4. Wales PW, Kosar C, Carricato M, et al. Ethanol lock therapy to reduce the incidence of catheter-related bloodstream infections in home parenteral nutrition patients with intestinal failure: preliminary experience. J Pediatr Surg. 2011;46:951-956.
5. Onland W, Shin CE, Fustar S, et al. Ethanol-lock technique for persistent bacteremia of long-term intravascular devices in pediatric patients. Arch Pediatr Adolesc Med. 2006; 160:1049-1053.
6. Opilla MT, Kirby DF, Edmond MB. Use of ethanol lock therapy to reduce the incidence of catheter-related bloodstream infections in home parenteral nutrition patients. JPEN J Parenter Enteral Nutr. 2007;31:302-305.
7. Mouw E, Chessman K, Lesher A, et al. Use of an ethanol lock to prevent catheter-related infections in children with short bowel syndrome. JPediatr Surg. 2008;43:1025-1029.
8. Metcalf SC, Chambers ST, Pithie AD. Use of ethanol locks to prevent recurrent central line sepsis. J Infect. 2004;49:20-22.
9. Blackwood RA, Klein KC, Micel LN, et al. Ethanol locks therapy for resolution of fungal catheter infections. Pediatr Infect Dis J. 2011;30: 1105-1107.
10. Valentine KM. Ethanol lock therapy for catheter-associated blood stream infections in a pediatric intensive care unit. Pediatr Crit Care Med. 2011;12: e292-e296.
11. Whelan K, Myers CE. Safety of probiotics in patients receiving nutritional support: a systematic review of case reports, randomized controlled trials, and nonrandomized trials. Am J Clin Nutr. 2010;91:687-703.
12. Mermel LA, Allon M, Bouza E, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;49:1-45.
13. Buckler BS, Sams RN, Goei VL, et al. Treatment of central venous catheter fungal infection using liposomal amphoteric in-B lock therapy. Pediatr Infect Dis J. 2008;27:762-764.
14. d'Enfert C. Biofilms and their role in the resistance of pathogenic Candida to antifungal agents. Curr Drug Targets. 2006;7:465-470.
15. Ramage G, VandeWalle K, Bachmann SP, et al. In vitro pharmacodynamic properties of three antifungal agents against preformed Candida albicans biofilms determined by time-kill studies. Antimicrob Agents Chemother. 2002;46:3634-3636.
16. Kuhn DM, George T, Chandra J, et al. Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echino-candins. Antimicrob Agents Chemother. 2002;46:1773-1780.
17. Bachmann SP, Vande Walle K, Ramage G, et al. In vitro activity of caspo-fungin against Candida albicans biofilms. Antimicrob Agents Chemother. 2002;46:3591-3596.